Multidisciplinary insights on helping patients with ADHD during the COVID-19 pandemic, medication abuse, and other factors affecting care.
Amber Schilling, PharmD
Advertisement
Articles by Amber Schilling, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Transcranial Magnetic Stimulation in Sports Performance: Promise, Physiology, and Precaution
2
NDA Submission: Olanzapine Extended-Release Injectable Suspension for Treatment of Schizophrenia
3
Semaglutide Potentially Protective Against Nephrotoxicity Caused by Lithium
4
FDA Accepts NDA for TRN-257 for Treatment of Narcolepsy and Idiopathic Hypersomnia
5
